What kind of thrombotic diseases is aspirin enteric-coated sustained-release tablets effective for?

Aspirin is an antiplatelet drug, which is mainly used to prevent and treat arterial thromboembolic diseases. The inhibitory effect on venous thromboembolic diseases and intracardiac thrombosis is weak, and the antithrombotic effect is obviously weaker than that of anticoagulant drugs, so it is not the first choice.

Ning Jie adopts advanced enteric-coated sustained-release technology. The original aspirin is slowly dissolved and released in the intestine, and slowly absorbed, so that the blood concentration becomes more stable, further reducing the irritation to the gastrointestinal tract, which is safer and more effective. This technology has obtained 20 13 national invention patent certificate.

Ningjie 50mg/ tablet specification, incorporating the concept of individualized treatment, is more convenient for dose adjustment. Especially in the field of cerebrovascular diseases, as a primary preventive drug, the initial dose of 50mg is more in line with the clinical drug demand.